Stock listing

30J Stock Price, News, Filings & Events — Ideaya Biosciences, Inc.

Selected listing: 30J · DUS · EUR · DE

This page tracks Ideaya Biosciences, Inc.'s 30J:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 30J:DUS. 30J:DUS is the stock-level entry point for investors researching Ideaya Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ideaya Biosciences, Inc. (Ticker: IDYA) is a public company operating in the American market, focusing on the development of targeted therapies for cancer and other diseases. The company has a market capitalization of approximately $3.37 billion. Ideaya is dedicated to advancing its innovative drug candidates through clinical development to address unmet medical needs.

30J:DUSEURDEUpdated August 21, 2026
Ideaya Biosciences, Inc. logo
Ticker
30J:DUS
Asset type
Stock
Market cap
$3.83B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
DUS
Currency
EUR

Ideaya Biosciences, Inc. 30J:DUS stock context

This page tracks Ideaya Biosciences, Inc.'s 30J:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 30J:DUS. 30J:DUS is the stock-level entry point for investors researching Ideaya Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ideaya Biosciences, Inc. (Ticker: IDYA) is a public company operating in the American market, focusing on the development of targeted therapies for cancer and other diseases. The company has a market capitalization of approximately $3.37 billion. Ideaya is dedicated to advancing its innovative drug candidates through clinical development to address unmet medical needs.

Latest news from Ideaya Biosciences, Inc.

All Ideaya Biosciences, Inc. news →

Research Ideaya Biosciences, Inc.

Alternate listings